about
Recurrent pericarditis during meningococcal meningitis. 2 case reports[Renal failure during treatment with Ambisome].Clinical presentation of leptospirosis: a retrospective study of 34 patients admitted to a single institution in metropolitan France.Ritonavir-saquinavir dual protease inhibitor compared to ritonavir alone in human immunodeficiency virus-infected patients.Last generation triazoles for imported eumycetoma in eleven consecutive adultsValue of preoperative investigations in diagnosing prosthetic joint infection: retrospective cohort study and literature review.Amprenavir or fosamprenavir plus ritonavir in HIV infection: pharmacology, efficacy and tolerability profile.Clinical pharmacology, efficacy and safety of atazanavir: a review.Optimizing combination rifampin therapy for staphylococcal osteoarticular infections.Capnocytophaga spp. involvement in bone infections: a review.Update on blood culture-negative endocarditis.A retrospective study of 230 consecutive patients hospitalized for presumed travel-related illness (2000-2006).Prolonged suppressive antibiotic therapy for prosthetic joint infection in the elderly: a national multicentre cohort study.Impact of age on care pathways of people living with HIV followed up in hospital.[Recurrent tick-borne fever: a possible diagnosis in patients returning from Senegal].Yellow fever vaccine is safe and effective in HIV-infected patients.MALDI-TOF MS performance compared to direct examination, culture, and 16S rDNA PCR for the rapid diagnosis of bone and joint infections.Predictors of failure for prosthetic joint infections treated with debridement.Tenosynovitis of the wrist due to resistant Mycobacterium tuberculosis in a heart transplant patientUse of human papillomavirus genotyping and biomarkers for targeted screening of anal dysplasia in human immunodeficiency virus-infected patients.Outpatient parenteral antimicrobial therapy for infective endocarditis: a cost-effective strategy.Effect of twice-daily nevirapine on adherence in HIV-1-infected patients: a randomized controlled study.Should we systematically perform central nervous system imaging in patients with Whipple's endocarditis?Differential effect of ritonavir and indinavir on immune response to hepatitis C virus in HIV-1 infected patients.Mitochondrial abnormalities in patients with HIV-HCV co-infection as compared to patients with HCV mono-infection.Failure of antibiotic-lock technique using daptomycin for subcutaneous injection ports in a patient on home parenteral nutrition.Salvage therapy with amprenavir and ritonavir: prospective study in 17 heavily pretreated patients.Simultaneous quantitative assay of six HIV protease inhibitors, one metabolite, and two non-nucleoside reverse transcriptase inhibitors in human plasma by isocratic reversed-phase liquid chromatography.Undetectable HIV-1 viral load in the fluid of bullous skin lesion in a patient receiving highly active antiretroviral therapy.Use of high-performance liquid chromatography (HPLC) to monitor beta-lactam plasma concentrations during the treatment of endocarditis.[Primary cutaneous cryptococcosis in transplant recipients: a report of two cases].The use of drug resistance algorithms and genotypic inhibitory quotient in prediction of lopinavir-ritonavir treatment response in human immunodeficiency virus type 1 protease inhibitor-experienced patients.Simultaneous quantitative assay of atazanavir and 6 other HIV protease inhibitors by isocratic reversed-phase liquid chromatography in human plasma.[HIV, only the tip of the iceberg in Burundi].Aseptic meningitis associated with lamotrigine: report of two cases.Stavudine plus didanosine and nevirapine in antiretroviral-naive HIV-infected adults: preliminary safety and efficacy results. VIRGO Study Team.[Characteristics and health care pathways of HIV-infected patients in Mayotte (1990-2010)].Diabetes in patients with pasteurellosis.Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavir[Acute kidney failure due to tubulo-interstitial nephropathy after treatment with ciprofloxacin]
P50
Q28198677-620206FD-AE27-4664-BD80-6131189E57B4Q31549245-E407EDD0-DBD3-48C7-8B60-455A98981231Q33365754-48FB9955-D556-4938-9F7B-97D268EC9A7CQ33983571-6DD7605C-2607-4287-8BC4-D1964F00337BQ34315079-02CF3879-9B98-4BA2-B715-DE128C819BAEQ35861472-FABE6D7A-EF1B-4D39-AD74-C0994027C0CCQ36062034-5B6DBD80-4A53-4DBB-A88D-51CC7D81A86DQ37622972-D960C981-EBAD-487D-B075-118643C9853FQ38075207-1E1A9778-C4DA-4EB7-8725-404EF5854938Q38104047-059EE12A-9120-4820-8966-3D87A61437F3Q38283950-24E40F90-BD74-419E-9D69-48DE8AA2D8FCQ39171835-3E8D23D2-A790-4B2C-A51C-3BEB28FE1433Q39367796-4DEA21E1-A5AF-4A00-9BA3-0927D91F1E10Q39661882-E613E6F8-A54E-49C4-9A9C-7E961B857CD8Q40415151-DB03551B-D2BC-4271-95B1-B32D7F35D62EQ40536294-6506FB32-4150-40DD-B8D9-FD64DB645A00Q40767786-BEDAFAFB-3BD0-41DA-BC71-77A2FB6052B0Q40853909-96D373D1-0DF5-41E1-81E4-8BCE5FC3F2C8Q41040466-3667445A-4631-4214-A933-2F7F937FCDA1Q41482852-28C1C809-CCCA-4FBA-AC03-4321CE5630D1Q42206216-EFE770CD-1191-4C4A-BFE8-8217EABAC98FQ42640175-7CF59CDE-1283-4081-9EF1-49194F06DB90Q42870336-FA8ED802-B855-449E-A75D-61EC06B6B5DEQ42995449-ED563173-5E43-48A1-81E8-8958D5DE0710Q43035090-18810A21-40C2-43B4-91D6-771768A08D92Q43104242-20BA15DE-B023-4164-B16D-562CDC31E5A8Q43971699-C4A0B7B9-CE8D-4E01-BDD9-6A3C65F7C9D8Q44079819-1F5C86A7-DD04-44F4-9F4E-BA279A16E0CEQ44806983-F32CF1F0-47AA-4980-92BF-25BBE156E94AQ45222977-88BAC09C-7AF1-4513-A27E-8ED18514A2A2Q45264478-A655C81C-7D5D-4AEE-9135-1670E6C71C35Q45408515-40241931-CFA7-49C9-A57F-29036A02E050Q46500115-587BA4AF-3C06-47EA-BA74-A69711BC6334Q46838610-05C9A6C8-2E0C-4C22-976D-A3B68AC69EADQ46889861-E29EEE1E-215F-400F-9458-C2BB4F55207FQ53915457-F441340A-B468-4476-9B35-21CA7C096EC4Q54105678-9FFA030F-7A07-4088-8131-920EF6EA23A2Q54360755-B36EF701-FC30-4253-9836-123C87E17100Q56762682-C3B79055-8F34-49FF-A643-2213D5B04352Q67905339-3A4C004A-BD6A-490E-A80D-11457DAB5661
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Cédric Arvieux
@ast
Cédric Arvieux
@en
Cédric Arvieux
@es
Cédric Arvieux
@nl
type
label
Cédric Arvieux
@ast
Cédric Arvieux
@en
Cédric Arvieux
@es
Cédric Arvieux
@nl
prefLabel
Cédric Arvieux
@ast
Cédric Arvieux
@en
Cédric Arvieux
@es
Cédric Arvieux
@nl
P106
P31
P496
0000-0003-2332-2507